Cardiac Shock Wave Therapy Ameliorates Myocardial Ischemia in Patients With Chronic Refractory Angina Pectoris: A
Liu Weijing1, Fan Ximin1, Shen Jianying1
1Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.
Insights
Cardiac shock wave therapy (CSWT) offers a safe and effective non-invasive treatment for chronic refractory angina pectoris (CRAP). CSWT significantly improves patient symptoms and myocardial perfusion without adverse effects.
Area of Science:
- Cardiology
- Non-invasive therapies
Background:
- Chronic refractory angina pectoris (CRAP) presents a significant clinical challenge.
- Cardiac shock wave therapy (CSWT) is an emerging non-invasive treatment option.
Purpose of the Study:
- To evaluate the safety and efficacy of CSWT in patients with CRAP.
- To assess improvements in angina severity, quality of life, and myocardial perfusion.
Main Methods:
- Eighty-seven CRAP patients were randomized into CSWT (n=46) and control (n=41) groups.
- Evaluated Canadian Cardiovascular Society (CCS) grade, Seattle Angina Questionnaire (SAQ) score, 6-min walk test (6MWT), and D-SPECT myocardial perfusion.
- Monitored adverse events throughout the study.
Main Results:
- CSWT was well-tolerated, with no significant adverse events reported.
- Significant improvements observed in CCS grade, SAQ score, and 6MWT in the CSWT group (p < 0.05).
- Reduced ischemic areas on D-SPECT imaging post-CSWT, with no changes in the control group.
Conclusions:
- CSWT demonstrates potential to improve myocardial perfusion and alleviate clinical symptoms in CRAP patients.
- The therapy is safe and non-invasive, offering a viable treatment option for CRAP.
- Further research supports CSWT as a promising therapeutic strategy for refractory angina.
Abstract:
Background: Cardiac shock wave therapy (CSWT) is a non-invasive new option for the treatment of chronic refractory angina pectoris (CRAP). This study aimed to evaluate the safety and efficiency of CSWT in the treatment of CRAP. Methods: Eighty-seven patients with CRAP were randomly allocated into CWST group (n = 46) and Control group (n = 41). Canadian Cardiovascular Society (CCS) grade of angina pectoris, Seattle Angina Questionnaire (SAQ) score, 6-min walk test (6MWT), weekly dosage of nitroglycerin, and myocardial perfusion on D-SPECT were determined at baseline and during the follow-up period. Adverse events were also evaluated. Results: CSWT was well-tolerated in the CSWT patients. CSWT significantly improved the CCS grade, SAQ score, and 6MWT (p < 0.05). Imaging examinations showed that the ischemic area was reduced after CSWT. However, no significant changes were observed in the Control group. Conclusions: CSWT may improve the myocardial perfusion and reduce clinical symptoms without increasing adverse effects in CRAP patients. It provides a non-invasive and safe clinical therapy for CRAP patients. Clinical Trial registration: www.ClinicalTrials.gov, identifier: NCT03398096.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Cardiopulmonary Resuscitation IV: Pharmacological Management
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Angina IV: Management
Coronary Artery Disease V: Interprofessional Care
Angina V: Nursing Management


